These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 20102924

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Yamaguchi T, Kitai T, Miyamoto T, Kagiyama N, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Yamaguchi J, Iwai T, Hijikata S, Masuda R, Miyazaki R, Hara N, Nagata Y, Nozato T, Matsue Y.
    Am J Cardiol; 2018 Apr 15; 121(8):969-974. PubMed ID: 29477488
    [Abstract] [Full Text] [Related]

  • 23. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW, Lim CP, Gao F, Chen Q, Kawa LB, Ching CK, Sim DK.
    J Cardiovasc Med (Hagerstown); 2015 Sep 15; 16(9):583-90. PubMed ID: 25022929
    [Abstract] [Full Text] [Related]

  • 24. Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report.
    Roik M, Starczewska MH, Huczek Z, Kochanowski J, Opolski G.
    Acta Cardiol; 2008 Dec 15; 63(6):683-92. PubMed ID: 19157162
    [Abstract] [Full Text] [Related]

  • 25. Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy.
    Cho MS, Kim MS, Lee SE, Choi HI, Lee JB, Cho HJ, Lee HY, Choi JO, Jeon ES, Hwang KK, Chae SC, Baek SH, Kang SM, Choi DJ, Yoo BS, Ahn Y, Kim KH, Park HY, Cho MC, Oh BH, Kim JJ.
    Can J Cardiol; 2018 Sep 15; 34(9):1145-1152. PubMed ID: 30170669
    [Abstract] [Full Text] [Related]

  • 26. β-Blockers are associated with increased B-type natriuretic peptide levels differently in men and women in heart failure with preserved ejection fraction.
    Harada E, Mizuno Y, Ishii M, Ishida T, Yamada T, Kugimiya F, Yasue H.
    Am J Physiol Heart Circ Physiol; 2022 Aug 01; 323(2):H276-H284. PubMed ID: 35714176
    [Abstract] [Full Text] [Related]

  • 27. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, Butler J, Mohammed SF, Wu WC, Panjrath G, Zile MR, White M, Arundel C, Love TE, Blackman MR, Allman RM, Aronow WS, Anker SD, Fonarow GC, Ahmed A.
    J Am Coll Cardiol; 2017 Oct 10; 70(15):1861-1871. PubMed ID: 28982499
    [Abstract] [Full Text] [Related]

  • 28. Beta-blocker use and outcomes among hospitalized heart failure patients.
    Butler J, Young JB, Abraham WT, Bourge RC, Adams KF, Clare R, O'Connor C, ESCAPE Investigators.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2462-9. PubMed ID: 16781374
    [Abstract] [Full Text] [Related]

  • 29. Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.
    Setoguchi M, Hashimoto Y, Sasaoka T, Ashikaga T, Isobe M.
    Heart Vessels; 2015 Sep 20; 30(5):595-603. PubMed ID: 24935218
    [Abstract] [Full Text] [Related]

  • 30. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators.
    J Am Coll Cardiol; 2008 Jul 15; 52(3):190-9. PubMed ID: 18617067
    [Abstract] [Full Text] [Related]

  • 31. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, Fioretti PM.
    J Am Soc Echocardiogr; 2004 Mar 15; 17(3):253-61. PubMed ID: 14981424
    [Abstract] [Full Text] [Related]

  • 32. Characteristics and outcomes of heart failure hospitalization before implementation of a heart failure clinic: The PRECIC study.
    Marques I, Abreu S, Bertão MV, Ferreira B, Ramos RL, Lopes J, Nunes S, Mendonça D, Teixeira L.
    Rev Port Cardiol; 2017 Jun 15; 36(6):431-438. PubMed ID: 28579091
    [Abstract] [Full Text] [Related]

  • 33. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.
    Patel P, White DL, Deswal A.
    Am Heart J; 2007 Apr 15; 153(4):515-22. PubMed ID: 17383287
    [Abstract] [Full Text] [Related]

  • 34. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.
    Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R.
    J Cardiol; 2012 Jul 15; 60(1):23-30. PubMed ID: 22445598
    [Abstract] [Full Text] [Related]

  • 35. Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Nichols GA, Reynolds K, Kimes TM, Rosales AG, Chan WW.
    Am J Cardiol; 2015 Oct 01; 116(7):1088-92. PubMed ID: 26235928
    [Abstract] [Full Text] [Related]

  • 36. Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.
    Patel K, Fonarow GC, Ekundayo OJ, Aban IB, Kilgore ML, Love TE, Kitzman DW, Gheorghiade M, Allman RM, Ahmed A.
    Int J Cardiol; 2014 May 15; 173(3):393-401. PubMed ID: 24703206
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA, Doehner W, van der Horst IC, Anker SD, Babalis D, Roughton M, Coats AJ, Flather MD, van Veldhuisen DJ, SENIORS Investigators.
    Am J Cardiol; 2010 Jul 01; 106(1):78-86.e1. PubMed ID: 20609652
    [Abstract] [Full Text] [Related]

  • 39. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC.
    Am Heart J; 2014 Nov 01; 168(5):721-30. PubMed ID: 25440801
    [Abstract] [Full Text] [Related]

  • 40. Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure.
    Seicean S, Seicean A, Alan N, Plana JC, Budd GT, Marwick TH.
    Circ Heart Fail; 2013 May 01; 6(3):420-6. PubMed ID: 23425978
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.